6.
Traag V, Waltman L, van Eck N
. From Louvain to Leiden: guaranteeing well-connected communities. Sci Rep. 2019; 9(1):5233.
PMC: 6435756.
DOI: 10.1038/s41598-019-41695-z.
View
7.
Neurath M, Weigmann B, Finotto S, Glickman J, Nieuwenhuis E, Iijima H
. The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J Exp Med. 2002; 195(9):1129-43.
PMC: 2193714.
DOI: 10.1084/jem.20011956.
View
8.
Sandborn W, Feagan B, DHaens G, Wolf D, Jovanovic I, Hanauer S
. Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis. N Engl J Med. 2021; 385(14):1280-1291.
DOI: 10.1056/NEJMoa2033617.
View
9.
Fuss I, Neurath M, Boirivant M, Klein J, de La Motte C, Strong S
. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol. 1996; 157(3):1261-70.
View
10.
Feagan B, Sandborn W, Gasink C, Jacobstein D, Lang Y, Friedman J
. Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease. N Engl J Med. 2016; 375(20):1946-1960.
DOI: 10.1056/NEJMoa1602773.
View
11.
Neurath M
. Targeting immune cell circuits and trafficking in inflammatory bowel disease. Nat Immunol. 2019; 20(8):970-979.
DOI: 10.1038/s41590-019-0415-0.
View
12.
Feagan B, Danese S, Loftus Jr E, Vermeire S, Schreiber S, Ritter T
. Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial. Lancet. 2021; 397(10292):2372-2384.
DOI: 10.1016/S0140-6736(21)00666-8.
View
13.
Maul J, Loddenkemper C, Mundt P, Berg E, Giese T, Stallmach A
. Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease. Gastroenterology. 2005; 128(7):1868-78.
DOI: 10.1053/j.gastro.2005.03.043.
View
14.
Feagan B, Rutgeerts P, Sands B, Hanauer S, Colombel J, Sandborn W
. Vedolizumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2013; 369(8):699-710.
DOI: 10.1056/NEJMoa1215734.
View
15.
Wolf F, Angerer P, Theis F
. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 2018; 19(1):15.
PMC: 5802054.
DOI: 10.1186/s13059-017-1382-0.
View
16.
Schett G, McInnes I, Neurath M
. Reframing Immune-Mediated Inflammatory Diseases through Signature Cytokine Hubs. N Engl J Med. 2021; 385(7):628-639.
DOI: 10.1056/NEJMra1909094.
View
17.
Sturm G, Szabo T, Fotakis G, Haider M, Rieder D, Trajanoski Z
. Scirpy: a Scanpy extension for analyzing single-cell T-cell receptor-sequencing data. Bioinformatics. 2020; 36(18):4817-4818.
PMC: 7751015.
DOI: 10.1093/bioinformatics/btaa611.
View
18.
Neurath M
. Cytokines in inflammatory bowel disease. Nat Rev Immunol. 2014; 14(5):329-42.
DOI: 10.1038/nri3661.
View
19.
Speir M, Bhaduri A, Markov N, Moreno P, Nowakowski T, Papatheodorou I
. UCSC Cell Browser: visualize your single-cell data. Bioinformatics. 2021; 37(23):4578-4580.
PMC: 8652023.
DOI: 10.1093/bioinformatics/btab503.
View
20.
Harris C, Millman K, van der Walt S, Gommers R, Virtanen P, Cournapeau D
. Array programming with NumPy. Nature. 2020; 585(7825):357-362.
PMC: 7759461.
DOI: 10.1038/s41586-020-2649-2.
View